Faron Pharmaceuticals Limited (AIM:FARN) has repaid €1.6 million of debt owed to its convertible bondholder by issuing 3.4 million new shares rather than paying cash. New shares were issued for €0.4741 per share. They are due to begin trading on AIM and Nasdaq First North on 4 June.
The Markets by Proactive
Go to Proactive UK
Proactive’s coverage of London’s small caps continues on .com